Resources

WHERE TO GO FOR MORE INFORMATION

NONPROFITS AND TRADE GROUPS

Hemp Industries Association

https://www.thehia.org

National Cannabis Industry Association

https://thecannabisindustry.org

National Hemp Association

https://nationalhempassociation.org

Project CBD

https://www.projectcbd.org

U.S. Hemp Authority

ushempauthority.org

INSTITUTIONAL RESEARCH

Center for Medical Cannabis Research, University of California at San Diego

https://www.cmcr.ucsd.edu

International Cannabinoid Research Society

https://icrs.co/

International Research Center on Cannabis and Health

https://ircch.com

National Institutes of Health Research on Marijuana and Cannabinoids

https://www.drugabuse.gov/drugs-abuse/marijuana/nih-research-marijuana-cannabinoids

STUDIES CITED IN THIS BOOK
(IN ORDER OF CITATION IN THE BOOK)

The health effects of cannabis and cannabinoids: the current state of evidence and recommendations

National Academy of Sciences

https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state

Cannabidiol (CBD) Critical Review Report

World Health Organization: Expert Committee on Drug Dependency, Fortieth Meeting, Geneva, June 4-7, 2018

https://www.who.int/medicines/access/controlled-substances/CannabidiolCriticalReview.pdf

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial

Journal of the European College of Neuropsychopharmacology, May 2017

https://www.ncbi.nlm.nih.gov/pubmed/28576350

Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage

Neurotherapeutics, August 2015

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604178/

Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings

Addictive Behaviors, April 2013

https://www.ncbi.nlm.nih.gov/pubmed/23685330

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

Journal of Psychopharmacology, September 2010

https://journals.sagepub.com/doi/abs/10.1177/0269881110379283

Cannabidiol as a potential treatment for anxiety disorders

Neurotherapeutics, September 2015

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604171/

Cannabidiol as a therapeutic alternative for post-traumatic stress disorder: from bench research to confirmation in human trials

Frontiers in Neuroscience, July 2018

https://www.frontiersin.org/articles/10.3389/fnins.2018.00502/full

Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis

European Journal of Pain, July 2016

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/

Cannabidiol to Improve Mobility in People with Multiple Sclerosis

Frontiers in Neurology, March 2018

https://www.frontiersin.org/articles/10.3389/fneur.2018.00183/full

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

European Journal of Pharmacology, February 2007

https://www.ncbi.nlm.nih.gov/pubmed/17157290

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice

Autoimmunity, March 2006

https://www.ncbi.nlm.nih.gov/pubmed/16698671

Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life

Public Library of Science (PLOS) One, April 2011

https://www.ncbi.nlm.nih.gov/pubmed/21533029

A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study

Journal of Clinical Insight, June 2017

https://insight.jci.org/articles/view/93760

The endocannabinoid system in guarding against fear, anxiety and stress

Nature Review Neuroscience, November 2015

https://www.nature.com/articles/nrn4036

Cannabidiol in anxiety and sleep: a large case series

Permanente Journal, January 2019

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/

Regulation of nausea and vomiting by cannabinoids

British Journal of Pharmacology, August 2011

https://www.ncbi.nlm.nih.gov/pubmed/21175589

Cannabidiol for the treatment of psychosis in Parkinson’s disease

Journal of Psychopharmacology, September 2008

https://journals.sagepub.com/doi/abs/10.1177/0269881108096519

Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series

Journal of Clinical Pharmacy and Therapeutics, May 2014

https://onlinelibrary.wiley.com/doi/abs/10.1111/jcpt.12179

Cannabidiol treatment for refractory seizures in sturge-weber syndrome

Pediatric Neurology, June 2017

https://www.sciencedirect.com/science/article/abs/pii/S088789941730053X

The role of cannabinoids in dermatology

Journal of the American Academy of Dermatology, July 2017

https://www.jaad.org/article/S0190-9622(17)30308-0/abstract

Labeling accuracy of cannabidiol extracts sold online

Journal of the American Medical Association, November 2017

https://jamanetwork.com/journals/jama/fullarticle/2661569